← All trials
NCT00594594
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2007
- Primary completion
- May 31, 2009
- Completion date
- May 31, 2009
- First posted
- Jan 15, 2008
- Last posted
- Jul 7, 2009
- Enrollment
- 2
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- London Health Sciences CentreLead sponsor
- University of Western OntarioLead sponsor
- University of Western OntarioSponsor investigator
- University of Western OntarioStudy chair
- University of Western OntarioStudy director
- Ontario Neurotrauma FoundationCollaborator
- University of Western OntarioOfficial
- London Health Sciences CentreOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.